John Overdeck’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,200
Closed -$350K 3216
2019
Q4
$350K Sell
3,200
-1,400
-30% -$142K ﹤0.01% 3074
2019
Q3
$420K Buy
4,600
+1,200
+35% +$109K ﹤0.01% 2690
2019
Q2
$332K Buy
+3,400
New +$331K ﹤0.01% 2803
2019
Q1
Sell
-4,700
Closed -$384K 3090
2018
Q4
$384K Buy
+4,700
New +$427K ﹤0.01% 2274
2016
Q4
Sell
-3,000
Closed -$260K 3159
2016
Q3
$260K Buy
3,000
+1,000
+50% +$100K ﹤0.01% 2836
2016
Q2
$213K Buy
+2,000
New +$206K ﹤0.01% 2723
2016
Q1
Sell
-12,000
Closed -$1.07M 2843
2015
Q4
$1.07M Sell
12,000
-1,000
-8% -$89.2K 0.01% 1461
2015
Q3
$1.18M Buy
+13,000
New +$1.3M 0.01% 1101

Other funds holding CRI

John Overdeck's CRI Position: Q2 2026 in Review

John Overdeck increased its Carter's (CRI) stake by 201% in Q2 2026, buying an estimated $9.15M and bringing the position to 362,068 shares worth $14.9M. The position accounts for 0.01% of the portfolio, ranked #1230.

John Overdeck first reported a position in CRI in Q2 2013 and has held it in 20 quarters since. The position peaked at $44M in Q1 2016. 285 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • John Overdeck held 362,068 shares of Carter's worth $14.9M as of Q2 2026.
  • John Overdeck bought 241,867 Carter's shares in Q2 2026, an estimated $9.15M.
  • Carter's made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1230 holding.
  • John Overdeck first reported a position in Carter's in Q2 2013 and has held it in 20 quarters since.
  • John Overdeck's Carter's position peaked at $44M in Q1 2016.
  • 285 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.